Salvage irreversible electroporation for radio-recurrent prostate cancer

Nature Reviews Urology, Published online: 01 March 2023; doi:10.1038/s41585-023-00750-1Focal ablative therapy has emerged as a treatment option in radio-recurrent prostate cancer to obtain local control of disease and spare patients severe salvage-treatment-related complications. Irreversible electroporation holds the potential to become the standard ablative modality in prostate cancer owing to reliable ablation results, the electricity-based effect and an acceptable adverse-effect profile.
Source: Nature Reviews Urology - Category: Urology & Nephrology Authors: Source Type: research